Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9604 posts found.

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022 Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …
News

New study shares effectiveness of asthma drug compared to standard of care

December 19, 2022 Research and Development

The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially …
News

Targeted imaging agent for lung cancer surgery approved by FDA

December 19, 2022 Research and Development

The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous …
News

CDC provides $12.5m grant to study real-world effectiveness of vaccines

December 16, 2022 Research and Development

The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, …
News

New blood test appears to detect hidden cancer

December 16, 2022 Research and Development

Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy …
News

Merck and Moderna’s mRNA cancer vaccine is successful in efficacy trial

December 14, 2022 Research and Development

Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the …
News

ClearPoint recruits first patient in laser therapy study to treat Glioblastoma

December 14, 2022 Research and Development

California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser …
News

AI model predicts CVD risk from single chest radiograph

December 14, 2022 Research and Development

A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current …
News

Autolus announces positive primary endpoint data in FELIX trial

December 13, 2022 Research and Development

Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in …
News

Seagen shares data for Adcetris combination for Hodgkin Lymphoma

December 13, 2022 Research and Development

Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful …
News

New blood cancer treatment appears successful for most trial patients

December 12, 2022 Research and Development

A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 …
News

Positive results for BioVie’s Parkinson’s and Alzheimer’s phase 2 trials

December 6, 2022 Research and Development

BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease …
News
national-cancer-institute-uurfmwa25f0-unsplash

Nkarta data supports natural killer cells in cancer treatment

December 6, 2022 Research and Development

San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is …
News

Innovent Biologics and UNION Therapeutics announce first dosing of Chinese subject in phase 1 study

December 5, 2022 Research and Development

Innovent Biologics, a biopharmaceutical company which develops, manufactures and commercialises medicines for the treatment of illnesses within the scope of …
News

Amgen’s obesity drug appears promising with few side effects

December 5, 2022 Research and Development

Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026